Serum Urate, Metabolic Syndrome, and Cardiovascular Risk Factors. A Population-Based Study
- 3 July 2008
- journal article
- research article
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 27 (6) , 620-623
Abstract
We studied the associations between serum urate levels (determined in 503 subjects from a population of 1,344 subjects living in northern Madrid) and both the metabolic syndrome (MS) (defined by the Adult Treatment Panel III criteria) and C-reactive protein (CRP, determined in 382 subjects). MS was diagnosed in 25% (95%CI, 21–28%) and was associated with hyperuricemia (p<0.001). There was a graded increase in serum urate levels with increasing number of MS components. Urate concentrations significantly correlated with waist circumference (r=0,455, p<0.01). Serum urate was not independently associated with CRP levels. This study shows that serum urate levels are associated with the presence of MS and each of its features.Keywords
This publication has 5 references indexed in Scilit:
- Prevalence of the Metabolic Syndrome in Individuals with HyperuricemiaThe American Journal of Medicine, 2007
- Associations of Serum Uric Acid With Markers of Inflammation, Metabolic Syndrome, and Subclinical Coronary AtherosclerosisAmerican Journal of Hypertension, 2007
- Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based StudyAmerican Journal of Hypertension, 2006
- Definition of Metabolic SyndromeCirculation, 2004
- Relations of Hyperuricemia with the Various Components of the Insulin Resistance Syndrome in Young Black and White Adults: The CARDIA StudyAnnals of Epidemiology, 1998